Cargando…

HSP90 inhibitor 17-DMAG exerts anticancer effects against gastric cancer cells principally by altering oxidant-antioxidant balance

Heat shock protein 90 (HSP90) stabilizes numerous oncoproteins and, therefore, its inhibition has emerged as a promising antineoplastic strategy for diverse malignancies. In this study, we determined the therapeutic effects and mechanisms of action of a specific HSP90 inhibitor, 17-dimethylamino-eth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jeong Goo, Lee, Sang Chul, Kim, Ok-Hee, Kim, Kee-Hwan, Song, Kyo Young, Lee, Sang Kuon, Choi, Byung Jo, Jeong, Wonjun, Kim, Say-June
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593576/ https://www.ncbi.nlm.nih.gov/pubmed/28915605 http://dx.doi.org/10.18632/oncotarget.17007

Ejemplares similares

Everolimus Plus Ku0063794 Regimen Promotes Anticancer Effects against Hepatocellular Carcinoma Cells through the Paradoxical Inhibition of Autophagy
por: Lee, Sang Chul, et al.
Publicado: (2018)

Does Korea's current diagnosis-related group-based reimbursement system appropriately classify appendectomy patients?
por: Kim, Kee-Hwan, et al.
Publicado: (2016)

Development and Characterization of PLGA Nanoparticles Containing 17-DMAG, an Hsp90 Inhibitor
por: Cruz, Kercia P., et al.
Publicado: (2021)

Potentiation of the anticancer effects of everolimus using a dual mTORC1/2 inhibitor in hepatocellular carcinoma cells
por: Kim, Jong-Ok, et al.
Publicado: (2016)

17-DMAG dually inhibits Hsp90 and histone lysine demethylases in alveolar rhabdomyosarcoma
por: Singh, Shivendra, et al.
Publicado: (2020)

17-DMAG, an HSP90 Inhibitor, Ameliorates Multiple Organ Dysfunction Syndrome via Induction of HSP70 in Endotoxemic Rats
por: Wang, Yi-Li, et al.
Publicado: (2016)

Determination of optimized oxygen partial pressure to maximize the liver regenerative potential of the secretome obtained from adipose-derived stem cells
por: Lee, Sang Chul, et al.
Publicado: (2017)

The Hsp90 Inhibitor 17-DMAG Attenuates Hyperglycemia-Enhanced Hemorrhagic Transformation in Experimental Stroke
por: Zhang, Jiaming, et al.
Publicado: (2021)

The anti-oncogenic effect of 17-DMAG via the inactivation of HSP90 and MET pathway in osteosarcoma cells
por: KAWANO, MASANORI, et al.
Publicado: (2023)

IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression
por: Lee, Sang Chul, et al.
Publicado: (2015)

Lipopolysaccharide preconditioning of adipose-derived stem cells improves liver-regenerating activity of the secretome
por: Lee, Sang Chul, et al.
Publicado: (2015)

Hypoxia attenuates Hsp90 inhibitor 17-DMAG-induced cyclin B1 accumulation in hepatocellular carcinoma cells
por: Zhang, Jianming, et al.
Publicado: (2016)

HSP90 Inhibitor, 17-DMAG, Alone and in Combination with Lapatinib Attenuates Acquired Lapatinib-Resistance in ER-positive, HER2-Overexpressing Breast Cancer Cell Line
por: Lee, Hye Jin, et al.
Publicado: (2020)

The feasibility of single-port laparoscopic appendectomy using a solo approach: a comparative study
por: Kim, Say-June, et al.
Publicado: (2016)

The utility of the preoperative neutrophil-to-lymphocyte ratio in predicting severe cholecystitis: a retrospective cohort study
por: Lee, Sang Kuon, et al.
Publicado: (2014)

Oral administration of an HSP90 inhibitor, 17-DMAG, intervenes tumor-cell infiltration into multiple organs and improves survival period for ATL model mice
por: Ikebe, E, et al.
Publicado: (2013)

P-glycoprotein confers acquired resistance to 17-DMAG in lung cancers with an ALK rearrangement
por: Kim, Hee Joung, et al.
Publicado: (2015)

Traditional and Novel Mechanisms of Heat Shock Protein 90 (HSP90) Inhibition in Cancer Chemotherapy Including HSP90 Cleavage
por: Park, Sangkyu, et al.
Publicado: (2019)

Y‐632 inhibits heat shock protein 90 (Hsp90) function by disrupting the interaction between Hsp90 and Hsp70/Hsp90 organizing protein, and exerts antitumor activity in vitro and in vivo
por: Wang, Wenqian, et al.
Publicado: (2016)

DMAG, a novel countermeasure for the treatment of thrombocytopenia
por: Lin, Jing, et al.
Publicado: (2021)

Enhancing viability and angiogenic efficacy of mesenchymal stem cells via HSP90α and HSP27 regulation based on ROS stimulation for wound healing
por: Seo, Inwoo, et al.
Publicado: (2023)

Hsp90 inhibitor NMS-E973 exerts the anticancer effect against glioblastoma via induction of PUMA-mediated apoptosis
por: Sun, Libo, et al.
Publicado: (2018)

Bruceantin targets HSP90 to overcome resistance to hormone therapy in castration-resistant prostate cancer
por: Moon, Sue Jin, et al.
Publicado: (2021)

Boosting the effects of hyperthermia-based anticancer treatments by HSP90 inhibition
por: Vriend, Lianne E.M., et al.
Publicado: (2017)

Heterocyclic Compounds as Hsp90 Inhibitors: A Perspective on Anticancer Applications
por: Ardestani, Mina, et al.
Publicado: (2022)

Epigallocatechin-3-gallate suppresses the expression of HSP70 and HSP90 and exhibits anti-tumor activity in vitro and in vivo
por: Tran, Phan LCHB, et al.
Publicado: (2010)

Hsp90 inhibitor HSP990 in very low dose upregulates EAAT2 and exerts potent antiepileptic activity
por: Sha, Longze, et al.
Publicado: (2020)

Different HSP90 Inhibitors Exert Divergent Effect on Myxoid Liposarcoma In Vitro and In Vivo
por: Vannas, Christoffer, et al.
Publicado: (2022)

Harnessing adipose-derived stem cells to release specialized secretome for the treatment of hepatitis B
por: Kim, Hee Ju, et al.
Publicado: (2021)

Impact of obesity on the short-term outcomes of single-port laparoscopic colectomy for colorectal cancer in the Asian population: A retrospective cohort study
por: Choi, Byung Jo, et al.
Publicado: (2017)

A novel HSP90 inhibitor, 17-DMAG, induces Tax down-regulation and its oral administration to ATL-model mice intervenes against the infiltration property of the ATL-like lymphocytes and provides extended survival period
por: Ikebe, Emi, et al.
Publicado: (2014)

Potentiation of the Anticancer Effects by Combining Docetaxel with Ku-0063794 against Triple-Negative Breast Cancer Cells
por: Jeon, Ye-Won, et al.
Publicado: (2022)

HSP90 inhibitor, AUY922, debilitates intrinsic and acquired lapatinib-resistant HER2-positive gastric cancer cells
por: Park, Kang-Seo, et al.
Publicado: (2018)

Unleashing the full potential of Hsp90 inhibitors as cancer therapeutics through simultaneous inactivation of Hsp90, Grp94, and TRAP1
por: Park, Hye-Kyung, et al.
Publicado: (2020)

Structural Basis for Design of New Purine-Based Inhibitors Targeting the Hydrophobic Binding Pocket of Hsp90
por: Shin, Sang Chul, et al.
Publicado: (2020)

Enhanced Therapeutic Potential of the Secretome Released from Adipose-Derived Stem Cells by PGC-1α-Driven Upregulation of Mitochondrial Proliferation
por: Lee, Jaeim, et al.
Publicado: (2019)

Casein kinase 2 phosphorylation of Hsp90 threonine 22 modulates chaperone function and drug sensitivity
por: Mollapour, Mehdi, et al.
Publicado: (2011)

Designed hybrid TPR peptide targeting Hsp90 as a novel anticancer agent
por: Horibe, Tomohisa, et al.
Publicado: (2011)

Synergistic activity of Hsp90 inhibitors and anticancer agents in pancreatic cancer cell cultures
por: Daunys, Simonas, et al.
Publicado: (2019)

A rare collision tumor comprising intracystic papillary neoplasm associated with adenocarcinoma and angiosarcoma in the gallbladder
por: Park, Geon, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f4gmeeg5p8pvhmms6g3b6efl83